Specifications

• Conjugation:
  Unconjugated
• Protein/peptide type:
  Recombinant
• Source:
  HEK293 cells
• Species:
  Human
• Storage conditions:
  –20 °C
• Endotoxin content:
  Less than 1,0 EU per μg by the LAL method.
• Biological activity:
  Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human B7-H3, His Tag at 2 μg/ml (100 μl/well) can bind Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 with a linear range of 0,3-5 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilised Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 at 2 μg/ml (100 μl/well) can bind Human B7-H3, His Tag with a linear range of 0,01-0,156 μg/ml (Routinely tested).; Human B7-H3, His Tag inhibits Anti-CD3-induced proliferation of PBMC. The EC50 for this effect is 2,24-3,36 μg/ml (Routinely tested)
• Gene ID:
  Q5ZPR3-2
• Carrier-free:
  Y
• Protease-free:
  Y
• Animal-free:
  Y
• Protein synonyms:
  B7 homolog 3|B7-H3|CD276
• Protein/peptide name:
  B7-H3
• Purity:
  >95%
• Molecular weight:
  25,2 kDa
• Endotoxin level:
  Low
• Formulation:
  Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation
• Nuclease-free:
  Y
• Shipping temperature:
  Powder,RT